Related Experiment Video
Updated: Aug 17, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Surgical correction of hyperlipoproteinemia in patients with ischemic heart disease]
Insights
Partial ileal bypass surgery significantly improved hyperlipoproteinemia in patients with coronary heart disease (CHD). The procedure lowered blood lipids and increased beneficial high-density lipoproteins, aiding atherosclerosis regression.
Area of Science:
- Cardiovascular Surgery
- Metabolic Disorders
- Vascular Biology
Context:
- Hyperlipoproteinemia and atherosclerosis are significant risk factors for coronary heart disease (CHD).
- Existing therapies for drug-resistant hyperlipoproteinemia in CHD patients are often insufficient.
- Partial ileal bypass has shown promise in animal models for managing these conditions.
Purpose:
- To evaluate the efficacy of partial ileal bypass surgery in patients with CHD and hyperlipoproteinemia resistant to conventional treatments.
- To assess the long-term effects of the surgical intervention on lipid profiles, clinical symptoms, and atherosclerosis markers.
Summary:
- The study involved 34 patients with CHD and hyperlipoproteinemia who underwent partial ileal bypass surgery.
- Follow-up for up to five years revealed a persistent reduction in blood lipids and atherogenic lipoproteins.
- Patients experienced fewer angina attacks, an improved CHD course, and a significant increase in high-density lipoprotein cholesterol (average 85.3%).
- A notable decrease (45.8%) in the atherogenic index was observed, suggesting potential atherosclerosis regression.
Impact:
- Partial ileal bypass surgery offers a viable therapeutic option for managing complex hyperlipoproteinemia in CHD patients.
- The procedure demonstrates a favorable impact on cardiovascular risk factors and disease progression.
- Sustained improvements in lipid profiles and atherogenic markers suggest a role in mitigating atherosclerosis development and promoting regression.
Abstract:
The experimental results obtained in 102 animals showing a beneficial effect of partial ileac bypass on hyperlipoproteinemia and experimentally-induced atherosclerosis prompted the authors to perform this surgical intervention in 34 patients with coronary heart disease (CHD) and attendant hyperlipoproteinemia resistant to therapeutic agents. The follow up period was up to five years. The patients exhibited a persistent and substantial decrease in blood lipids and atherogenic lipoproteins, a reduced incidence of angina attacks and an improved CHD course. Furthermore, the surgery resulted in a considerable and stable elevation of the cholesterol levels of antiatherogenic high density lipoproteins (by an average of 85,3%) and in a 45.8% decrease of the cholesterol coefficient of atherogenicity which contributes to atherosclerosis regression.
Related Concept Videos
Lipid Digestion
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease III: Interprofessional Care

